Literature DB >> 21707862

Pet therapy in elderly patients with mental illness.

Francesca Moretti1, Diana De Ronchi, Virginia Bernabei, Lucia Marchetti, Barbara Ferrari, Claudia Forlani, Francesca Negretti, Cleta Sacchetti, Anna Rita Atti.   

Abstract

BACKGROUND: To evaluate the effects of pet therapy on cognitive function, mood and perceived quality of life on elderly inpatients (mean age 84.7 years; 95.2% women) affected by dementia, depression and psychosis.
METHODS: Mini-Mental State Examination (MMSE) and 15-items Geriatric Depression Scale (GDS) were administered to 10 patients (pet group) and 11 controls (control group) together with a self-perceived quality-of-life questionnaire, before and after a pet therapy intervention that lasted 6 weeks. MMSE and GDS mean scores were compared between and within groups by Student's t-test.
RESULTS: Both the pet group and control group improved on GDS and MMSE. Within the pet group, GDS symptoms decreased by 50% (from 5.9 to 2.7, P= 0.013), whereas mean MMSE score increased by 4.5 (P= 0.060). The between group comparison showed a positive effect of pet therapy intervention on GDS (P= 0.070). Most of the participants reported an improvement of their perceived quality of life.
CONCLUSIONS: Pet therapy is efficient in improving depressive symptoms and cognitive function in residents of long-term care facilities with mental illness.
© 2011 The Authors; Psychogeriatrics © 2011 Japanese Psychogeriatric Society.

Entities:  

Mesh:

Year:  2010        PMID: 21707862     DOI: 10.1111/j.1479-8301.2010.00329.x

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  30 in total

Review 1.  [Depression in old age, part 2 : Comorbidity and treatment].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2016-02-11       Impact factor: 1.281

Review 2.  [Animal-assisted interventions in acute inpatient geriatrics].

Authors:  Jacqueline Dreseler; Christiane Kugler
Journal:  Z Gerontol Geriatr       Date:  2019-02-18       Impact factor: 1.281

3.  Predictors of depressive symptoms following the Great East Japan earthquake: A prospective study.

Authors:  Toru Tsuboya; Jun Aida; Hiroyuki Hikichi; S V Subramanian; Katsunori Kondo; Ken Osaka; Ichiro Kawachi
Journal:  Soc Sci Med       Date:  2016-05-20       Impact factor: 4.634

4.  Functional Outcomes in a Randomized Controlled Trial of Animal-Assisted Therapy on Middle-Aged and Older Adults with Schizophrenia.

Authors:  Chyi-Rong Chen; Chi-Fa Hung; Yi-Wen Lee; Wei-Ting Tseng; Mei-Li Chen; Tzu-Ting Chen
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

5.  [Animal-assisted therapy for demented patients in acute care hospitals].

Authors:  R Püllen; M Coy; B Hunger; G Koetter; M Spate; A Richter
Journal:  Z Gerontol Geriatr       Date:  2013-04       Impact factor: 1.281

6.  Animal-assisted therapy for dementia.

Authors:  Nai Ming Lai; Sharon Mei Wern Chang; Siok Shen Ng; Shir Ley Tan; Nathorn Chaiyakunapruk; Fiona Stanaway
Journal:  Cochrane Database Syst Rev       Date:  2019-11-25

Review 7.  The benefit of pets and animal-assisted therapy to the health of older individuals.

Authors:  E Paul Cherniack; Ariella R Cherniack
Journal:  Curr Gerontol Geriatr Res       Date:  2014-11-16

8.  Effects of Dog-Assisted Therapies on Cognitive Mnemonic Capabilities in People Affected by Alzheimer's Disease.

Authors:  Fausto Quintavalla; Simona Cao; Diana Spinelli; Paolo Caffarra; Fiammetta M Rossi; Giuseppina Basini; Alberto Sabbioni
Journal:  Animals (Basel)       Date:  2021-05-11       Impact factor: 2.752

Review 9.  Complementary psychosocial interventions in child and adolescent psychiatry: pet assisted therapy.

Authors:  Susmita Chandramouleeswaran; Paul Swamidhas Sudhakar Russell
Journal:  Indian J Psychol Med       Date:  2014-01

Review 10.  Lifestyle medicine for depression.

Authors:  Jerome Sarris; Adrienne O'Neil; Carolyn E Coulson; Isaac Schweitzer; Michael Berk
Journal:  BMC Psychiatry       Date:  2014-04-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.